MONEY

Nxera Pharma GAAP EPS of ¥15.86, revenue of ¥18.91B; reaffirms FY 2026 outlook

ByFinance Desk

Aug 7, 2026 , , , , , , , , ,

Nxera Pharma GAAP EPS of ¥15.86, revenue of ¥18.91B; reaffirms FY 2026 outlook

Source link

By Finance Desk

Related Post

MONEY

MDA Space Non-GAAP EPS of $0.36 beats by $0.10, revenue of $498.6M beats by $180.04M

Aug 7, 2026 Finance Desk
MONEY

Kawasaki Heavy Industries reports Q1 results; raises FY 2026 outlook

Aug 7, 2026 Finance Desk
MONEY

Karman signals $730M-$745M 2026 revenue outlook while targeting 20%-25% annual organic growth (NYSE:KRMN)

Aug 7, 2026 Finance Desk

Leave a Reply

You missed

NEWS TODAY

Who Is Liable When AI Goes Rogue? Legal Risks Grow Over Autonomous AI

Aug 7, 2026 News Desk
SHOW BIZ

AI music company wants to press users’ creations onto vinyl records

Aug 7, 2026 News Desk
POLITICS

Pragmatic Bipartisanship? The Two Faces of US Policy Toward Venezuela

Aug 7, 2026 Politics Desk
SPORT

Cristian Romero: Atletico Madrid hold talks over move for Tottenham captain

Aug 7, 2026 Sports Desk

Discover more from Occasional Digest

Subscribe now to keep reading and get access to the full archive.

Continue reading